S109: ONCOGENIC DEUBIQUITINATION CONTROLS TYROSINE KINASE SIGNALING AND THERAPY RESPONSE IN ACUTE LYMPHOBLASTIC LEUKEMIA

S109: ONCOGENIC DEUBIQUITINATION CONTROLS TYROSINE KINASE SIGNALING AND THERAPY RESPONSE IN ACUTE LYMPHOBLASTIC LEUKEMIA

Bibliographic Details
Main Authors:	P. Ntziachristos, Q. Jin, B. Gutierrez
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000843332.37868.11

Similar Items

FLT3 tyrosine kinase in acute non-lymphoblastic leukemias
by: A. S. Bavykin, et al.
Published: (2022-11-01)

Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy
by: Simona Soverini, et al.
Published: (2018-02-01)

Oncogene-Induced Reprogramming in Acute Lymphoblastic Leukemia: Towards Targeted Therapy of Leukemia-Initiating Cells
by: Vincent Fregona, et al.
Published: (2021-11-01)

Tyrosine kinase inhibitors and reduced-dose chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia
by: Chunping Wu, et al.
Published: (2022-12-01)

Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibition
by: Xinhua Xiao, et al.
Published: (2020-06-01)

TYROSINE KINASE INHIBITORS PLUS HYPER-CVAD FOR THE FRONTLINE TREATMENT OF PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
by: R.D. Portugal, et al.
Published: (2020-11-01)

JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia
by: Mansour, Marc R., et al.
Published: (2018)

The Plasticity of Oncogene Addiction: Implications for Targeted Therapies Directed to Receptor Tyrosine Kinases
by: Vinochani Pillay, et al.
Published: (2009-05-01)

Relation between FMS-like tyrosine kinase 3 factor and hematological parameter in acute lymphoblastic leukemia patients by flow cytometry
by: Zainab Samir Al-Ali, et al.
Published: (2022-01-01)

Tyrosine Kinase Inhibitor for Treatment of Adult Allogeneic Hematopoietic Stem Cell Transplantation Candidate with Philadelphia-Positive Acute Lymphoblastic Leukemia
by: Lu Wang, et al.
Published: (2017-01-01)

Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia
by: Cristina Borin, et al.
Published: (2023-07-01)

Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
by: Petrushev B, et al.
Published: (2016-02-01)

Detection of the three fusion oncogenes of childhood acute lymphoblastic leukemia – Single centre experience
by: G. Krishna Sameera, et al.
Published: (2016-01-01)

Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia
by: Na Xu, et al.
Published: (2016-04-01)

Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous leukemia therapy
by: Zhenshu Xu, et al.
Published: (2009-03-01)

Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion
by: Gauthier Decool, et al.
Published: (2019-06-01)

Regulation of Beclin 1-Mediated Autophagy by Oncogenic Tyrosine Kinases
by: Silvia Vega-Rubín-de-Celis, et al.
Published: (2020-12-01)

The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability
by: Cosimo Lobello, et al.
Published: (2018-03-01)

Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia
by: Caterina Mezzatesta, et al.
Published: (2019-03-01)

Blockade of oncogenic NOTCH1 with the SERCA inhibitor CAD204520 in T cell acute lymphoblastic leukemia
by: Marchesini, M, et al.
Published: (2020)

ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia
by: Clemence Virely, et al.
Published: (2020-10-01)

NF-κB in T-cell Acute Lymphoblastic Leukemia: Oncogenic Functions in Leukemic and in Microenvironmental Cells
by: Mónica T. Fernandes, et al.
Published: (2010-11-01)

TOXICITY AND EFFICACY OF TYROSINE KINASE INHIBITORS IN COMBINATION WITH CHEMOTHERAPY IN PATIENT WITH RESISTANT Ph-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (CASE REPORT AND LITERATURE REVIEW)
by: K. I. Zarubina, et al.
Published: (2017-10-01)

Prognostic significance of a normal karyotype in adult patients with BCR-ABL1-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era
by: Ting Shi, et al.
Published: (2020-11-01)

Acute lymphoblastic leukemia
by: Martin Schrappe
Published: (2018-06-01)

Acute lymphoblastic leukemia
by: Toljić Branka G., et al.
Published: (2023-01-01)

Is stem cell transplantation still needed for adult Philadelphia chromosome-positive acute lymphoblastic leukemia receiving tyrosine kinase inhibitors therapy?: A systematic review and meta-analysis.
by: Ben Ponvilawan, et al.
Published: (2021-01-01)

An ensemble-acute lymphoblastic leukemia model for acute lymphoblastic leukemia image classification
by: Mei-Ling Huang, et al.
Published: (2024-01-01)

Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia
by: Huan Xu, et al.
Published: (2021-11-01)

Blockade of oncogenic notch1 with the new serca inhibitor cad204520 in t-cell acute lymphoblastic leukemia
by: M. Marchesini, et al.
Published: (2020-09-01)

Therapy of childhood acute lymphoblastic leukemia in resource-poor geospaces
by: Moisés M. Gallardo-Pérez, et al.
Published: (2023-06-01)

Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia
by: Ruyue Zheng, et al.
Published: (2020-11-01)

MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy
by: Umerez M, et al.
Published: (2017-03-01)

Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia
by: Kalpana K. Bhanumathy, et al.
Published: (2021-01-01)

Deubiquitination of Abelson tyrosine kinase: A novel regulatory mechanism targeting non‐small cell lung cancer glycolysis
by: Tong Yu, et al.
Published: (2024-02-01)

Function of Deubiquitinating Enzyme USP14 as Oncogene in Different Types of Cancer
by: Ying Zhu, et al.
Published: (2016-03-01)

Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies.
by: Hema Dave, et al.
Published: (2012-01-01)

Targeting an oncogenic kinase/phosphatase signaling network for cancer therapy
by: Xiao-Mei Qi, et al.
Published: (2018-07-01)

Tyrosine Kinase Inhibitors Available for Chronic Myeloid Leukemia: Efficacy and Safety
by: Valentín García-Gutiérrez, et al.
Published: (2019-07-01)

Molecular genetics monitoring of tyrosine kinase inhibitor therapy for chronic myeloid leukemia
by: S. I. Kutsev, et al.
Published: (2022-11-01)